Invasive group B streptococcus (GBS) disease in Norway 1996-2006

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 12, 2008, Pages 1193-1199

  Bergseng, H ^a,b,c   Rygg, M ^a,b,d   Bevanger, L ^a,b,c   Bergh, K ^a,b,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c LBK   (Norway)

^d NONE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; MEMBRANE PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; NORWAY; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ERYTHROMYCIN; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; NORWAY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 56349165089     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0565-8     Document Type: Article

References (36)

1. MA Trijbels-Smeulders LA Kollee AH Adriaanse JL Kimpen LJ Gerards 2004 Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe Pediatr Infect Dis J 23 172 173
2. SJ Schrag S Zywicki MM Farley AL Reingold LH Harrison LB Lefkowitz JL Hadler R Danila PR Cieslak A Schuchat 2000 Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis N Engl J Med 342 15 20
3. O Lyytikainen JP Nuorti E Halmesmaki P Carlson J Uotila R Vuento T Ranta H Sarkkinen M Ammala A Kostiala AL Jarvenpaa 2003 Invasive group B streptococcal infections in Finland: a population-based study Emerg Infect Dis 9 469 473
4. S Schrag R Gorwitz K Fultz-Butts A Schuchat 2002 Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC MMWR Recomm Rep 51 1 22
5. KM Boyer SP Gotoff 1986 Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis N Engl J Med 314 1665 1669
6. P Munoz A Llancaqueo M Rodriguez-Creixems T Pelaez L Martin E Bouza 1997 Group B streptococcus bacteremia in nonpregnant adults Arch Intern Med 157 213 216
7. GJ Tyrrell LD Senzilet JS Spika DA Kertesz M Alagaratnam M Lovgren JA Talbot 2000 Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. Sentinel Health Unit Surveillance System Site Coordinators J Infect Dis 182 168 173
8. MS Edwards CJ Baker 2005 Group B streptococcal infections in elderly adults Clin Infect Dis 41 839 847
9. MM Farley 2001 Group B streptococcal disease in nonpregnant adults Clin Infect Dis 33 556 561
10. RC Lancefield EH Freimer 1966 Type-specific polysaccharide antigens of group B streptococci J Hyg (Lond) 64 191 203
11. HC Slotved F Kong L Lambertsen S Sauer GL Gilbert 2007 A proposed new Streptococcus agalactiae serotype, serotype IX J Clin Microbiol 45 2929 2936
12. CJ Baker DL Kasper 1976 Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection N Engl J Med 294 753 756
13. CJ Baker MA Rench LC Paoletti MS Edwards 2007 Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults Vaccine 25 55 63
14. CJ Baker MA Rench M Fernandez LC Paoletti DL Kasper MS Edwards 2003 Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III J Infect Dis 188 66 73
15. K Fluegge S Supper A Siedler R Berner 2005 Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany Clin Infect Dis 40 760 763
16. LH Harrison JA Elliott DM Dwyer JP Libonati P Ferrieri L Billmann A Schuchat 1998 Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program J Infect Dis 177 998 1002
17. G Lindahl M Stalhammar-Carlemalm T Areschoug 2005 Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens Clin Microbiol Rev 18 102 127
18. L Bevanger AI Kvam JA Maeland 1995 A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies APMIS 103 731 736
19. BL Smith A Flores J Dechaine J Krepela A Bergdall P Ferrieri 2004 Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates & R4 protein pepsin sensitivity Indian J Med Res 119 suppl 213 220
20. M Stalhammar-Carlemalm L Stenberg G Lindahl 1993 Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections J Exp Med 177 1593 1603
21. C Larsson M Lindroth P Nordin M Stalhammar-Carlemalm G Lindahl I Krantz 2006 Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection Arch Dis Child Fetal Neonatal Ed 91 F403 F408
22. L Bevanger JA Maeland 1977 Type classification of group B streptococci by the fluorescent antibody test Acta Pathol Microbiol Scand [B] 85B 357 362
23. F Kong S Gowan D Martin G James GL Gilbert 2002 Serotype identification of group B streptococci by PCR and sequencing J Clin Microbiol 40 216 226
24. SM Borchardt B Foxman DO Chaffin CE Rubens PA Tallman SD Manning CJ Baker CF Marrs 2004 Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing J Clin Microbiol 42 146 150
25. SR Moyo JA Maeland L Bevanger 1999 Comparison of three different methods in monoclonal antibody-based detection of Streptococcus agalactiae protein serotype markers APMIS 107 263 269
26. X Zeng F Kong J Morgan GL Gilbert 2006 Evaluation of a multiplex PCR-based reverse line blot-hybridization assay for identification of serotype and surface protein antigens of Streptococcus agalactiae J Clin Microbiol 44 3822 3825
27. R Creti F Fabretti G Orefici HC von 2004 Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes J Clin Microbiol 42 1326 1329
28. P Aavitsland EA Hoiby A Lystad 1996 Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94 Acta Paediatr 85 104 105
29. KM Puopolo LC Madoff EC Eichenwald 2005 Early-onset group B streptococcal disease in the era of maternal screening Pediatrics 115 1240 1246
30. K Fluegge A Siedler B Heinrich J Schulte-Moenting MJ Moennig DB Bartels O Dammann KR von R Berner 2006 Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany Pediatrics 117 e1139 e1145
31. S Luck M Torny K d'Agapeyeff A Pitt P Heath A Breathnach AB Russell 2003 Estimated early-onset group B streptococcal neonatal disease Lancet 361 1953 1954
32. E Persson S Berg B Trollfors P Larsson E Ek E Backhaus BE Claesson L Jonsson G Radberg T Ripa S Johansson 2004 Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001 Clin Microbiol Infect 10 791 796
33. S Kalliola J Vuopio-Varkila AK Takala J Eskola 1999 Neonatal group B streptococcal disease in Finland: a ten-year nationwide study Pediatr Infect Dis J 18 806 810
34. JA Maeland L Bevanger RV Lyng 2005 Immunological markers of the R4 protein of Streptococcus agalactiae Clin Diagn Lab Immunol 12 1305 1310
35. E Persson S Berg L Bevanger K Bergh R Valso-Lyng B Trollfors 2007 Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins Clin Microbiol Infect 14 66 73
36. C Poyart A Tazi H Reglier-Poupet A Billoet N Tavares J Raymond P Trieu-Cuot 2007 Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci J Clin Microbiol 45 1985 1988